Lactic acidosis and bone marrow suppression due to oral hypoglycemic agents.
D000138:Acidosis / Q000139:chemically induced*; D000284:Administration, Oral; D000293:Adolescent; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007773:Lactates; D008297:Male; D010629:Phenformin / Q000009:adverse effects*; D013453:Sulfonylurea Compounds / Q000009:adverse effects*; D014042:Tolazamide / Q000009:adverse effects
D007773:Lactates; D013453:Sulfonylurea Compounds; D014042:Tolazamide; D010629:Phenformin